Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences
Abstract
The infralimbic (IL) and prelimbic (PL) regions of the prefrontal cortex are involved in behavioral responses observed during defensive reactions. Intra-PL or IL injections of cannabidiol (CBD), a major non-psychotomimetic cannabinoid present in the Cannabis sativa plant, result in opposite behavioral effects in the contextual fear conditioning (CFC) paradigm. The intra-PL effects of CBD are mediated by 5HT1A receptors and depend on previous stressful experiences but the mechanisms and effects of intra-IL CBD injected are unknown. To this aim the present work verified the effects of intra-IL administration of CBD on two animal models of anxiety, the elevated plus maze (EPM) and CFC. We also investigated if these effects were mediated by 5HT1A receptors and depended on previous stressful experience. Male Wistar rats received bilateral microinjections of vehicle, WAY100635 (5HT1A receptor antagonist, 0.37 nmol) and/or CBD (15, 30 or 60 nmol) before being submitted to the behavioral tests. Intra-IL CBD induced anxiolytic and anxiogenic in the EPM and CFC, respectively. To verify if these effects are influenced by the previous stressful experience (footshocks) in the CFC model, we tested the animals in the EPM 24h after a 2-h restraint period. The anxiolytic-like effect of CBD in the EPM disappeared when the animals were previously stressed. Both responses, i.e., anxiolytic and anxiogenic, were prevented by WAY100635, indicating that they involve local 5HT1A-mediated neurotransmission. Together these results indicate that CBD effects in the IL depend on the nature of the animal model, being influenced by previous stressful experiences and mediated by facilitation of 5HT1A receptors-mediated neurotransmission.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The anxiolytic-like effects produced by CBD injections into rat infralimbic or prelimbic cortices, BNST, and dPAG are attenuated by concomitant 5-HT1A-R antagonism.
“The anxiolytic-like effects produced by CBD injections into the rat infralimbic (Marinho et al., 2015) or prelimbic (Fogaca et al., 2014) cortices, BNST (Gomes et al., 2013; Gomes et al., 2012; Gomes et al., 2011) and dPAG (Campos et al., 2013a) are attenuated by concomitant 5-HT1A-R antagonism.”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Marinho et al., 2015
Cites
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,150 · see citing works
The amygdala: vigilance and emotion
Davis, M., & Whalen, P. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000812 · Cited by 2,882 · see citing works
Ongur, D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.206 · Cited by 2,627 · see citing works
LeDoux, J., Iwata, J., Cicchetti, P., & Reis, D. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-07-02517.1988 · Cited by 1,580 · see citing works
Sesack, S. R., Deutch, A. Y., Roth, R. H., & Bunney, B. S. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902900205 · Cited by 1,568 · see citing works
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535 · see citing works
Dissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527 · see citing works
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329 · see citing works
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315 · see citing works
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 963 · see citing works
Quirk, G. J., Likhtik, E., Pelletier, J. G., & Paré, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08800.2003 · Cited by 927 · see citing works
Encoding of conditioned fear in central amygdala inhibitory circuits
Ciocchi, S., Herry, C., Grenier, F., Wolff, S. B. E., Letzkus, J. J., Vlachos, I., Ehrlich, I., Sprengel, R., Deisseroth, K., Stadler, M. B., et al. (2010) · Nature · doi:10.1038/nature09559 · Cited by 924 · see citing works
Heidbreder, C. A., & Groenewegen, H. J. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.09.003 · Cited by 882 · see citing works
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878 · see citing works
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Marzo, V. D., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 851 · see citing works
Efferent projections of the infralimbic cortex of the rat
Hurley, K. M., Herbert, H., Moga, M. M., & Saper, C. B. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903080210 · Cited by 777 · see citing works
Innate and conditioned reactions to threat in rats with amygdaloid lesions.
Blanchard, D. C., & Blanchard, R. J. (1972) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0033521 · Cited by 753 · see citing works
Vidal-Gonzalez, I., Vidal-Gonzalez, B., Rauch, S. L., & Quirk, G. J. (2006) · Learning & Memory · doi:10.1101/lm.306106 · Cited by 705 · see citing works
Elevated anxiety and antidepressant-like responses in serotonin 5-HT 1A receptor mutant mice
Heisler, L. K., Chu, H.-M., Brennan, T. J., Danao, J. A., Bajwa, P., Parsons, L. H., & Tecott, L. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15049 · Cited by 704 · see citing works
Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety
Thomas, A., Burant, A., Bui, N., Graham, D., Yuva-Paylor, L. A., & Paylor, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1466-y · Cited by 698 · see citing works
Activity in Prelimbic Cortex Is Necessary for the Expression of Learned, But Not Innate, Fears
Corcoran, K., & Quirk, G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5327-06.2007 · Cited by 580 · see citing works
Safety and side effects of cannabidiol, a Cannabis sativa constituent
Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Alexandre S. Crippa, J. (2011) · Current Drug Safety · doi:10.2174/157488611798280924 · Cited by 558 · see citing works
Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497 · see citing works
Restricted cortical termination fields of the midline and intralaminar thalamic nuclei in the rat
Berendse, H. W., & Groenewegen, H. J. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90151-d · Cited by 494 · see citing works
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475 · see citing works
Animal models of anxiety disorders and stress
Campos, A. C., Fogaça, M. V., de Aguiar, D. C., & Guimarães, F. S. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1139 · Cited by 473 · see citing works
Izquierdo, A., Wellman, C. L., & Holmes, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0474-06.2006 · Cited by 459 · see citing works
Radley, J. J., Arias, C. M., & Sawchenko, P. E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4297-06.2006 · Cited by 456 · see citing works
The prefrontal cortex and the integration of sensory, limbic and autonomic information
Groenewegen, H. J., & Uylings, H. B. M. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)26003-2 · Cited by 442 · see citing works
Intrinsic connections of the rat amygdaloid complex: Projections originating in the basal nucleus
Savander, V., Go, C. ‐., LeDoux, J. E., & Pitkänen, A. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903610211 · Cited by 416 · see citing works
Bandler, R. J., & Carrive, P. (1988) · Brain Research · doi:10.1016/0006-8993(88)91465-5 · Cited by 386 · see citing works
Antianxiety effect of cannabidiol in the elevated plus-maze
Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379 · see citing works
Chapter 1 The emotional motor system
Holstege, G., Bandler, R., & Saper, C. B. (1996) · Progress in Brain Research · doi:10.1016/s0079-6123(08)61855-5 · Cited by 379 · see citing works
Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366 · see citing works
Effects of ipsapirone and cannabidiol on human experimental anxiety
Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700112 · Cited by 364 · see citing works
Campos, A. C., & Guimarães, F. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1168-x · Cited by 364 · see citing works
Milad, M. R., Vidal-Gonzalez, I., & Quirk, G. J. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.2.389 · Cited by 354 · see citing works
Ray, J. P., & Price, J. L. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903230204 · Cited by 326 · see citing works
Laurent, V., & Westbrook, R. F. (2009) · Learning & Memory · doi:10.1101/lm.1474609 · Cited by 311 · see citing works
Hajós, M., Richards, C. D., Székely, A. D., & Sharp, T. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00157-2 · Cited by 299 · see citing works
Maroun, M., & Richter-Levin, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04406.2003 · Cited by 293 · see citing works
Role of the medial prefrontal cortex in coping and resilience
Maier, S. F., & Watkins, L. R. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.039 · Cited by 292 · see citing works
Takagishi, M., & Chiba, T. (1991) · Brain Research · doi:10.1016/0006-8993(91)91677-s · Cited by 284 · see citing works
De, B. M., DeCola, J. P., Maren, S., & Fanselow, M. S. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03426.1998 · Cited by 278 · see citing works
The recombinant 5‐HT 1A receptor: G protein coupling and signalling pathways
Raymond, J. R., Mukhin, Y. V., Gettys, T. W., & Garnovskaya, M. N. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702723 · Cited by 239 · see citing works
Intrinsic connections of the rat amygdaloid complex: Projections originating in the lateral nucleus
Pitkänen, A., Stefanacci, L., Farb, C. R., Go, G. ‐., LeDoux, J. E., & Amaral, D. G. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903560211 · Cited by 238 · see citing works
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.004 · Cited by 207 · see citing works
Smith, Y., & Paré, D. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903420207 · Cited by 205 · see citing works
Bussey, T. J., Everitt, B. J., & Robbins, T. W. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.5.908 · Cited by 203 · see citing works
File, S. E., Mabbutt, P. S., & Hitchcott, P. K. (1990) · Psychopharmacology · doi:10.1007/bf02245751 · Cited by 197 · see citing works
Resstel, L. B. M., Joca, S. R. L., Moreira, F. A., Corrêa, F. M. A., & Guimarães, F. S. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.016 · Cited by 182 · see citing works
Petitet, F., Jeantaud, B., Reibaud, M., Impérato, A., & Dubroeucq, M. C. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00238-0 · Cited by 180 · see citing works
5-HT1A receptor knockout mouse as a genetic model of anxiety
Tóth, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01280-9 · Cited by 177 · see citing works
Gomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2036-z · Cited by 174 · see citing works
Campos, A. C., & Guimarães, F. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.017 · Cited by 172 · see citing works
Functional characteristics of heterologously expressed 5-HT receptors
Gerhardt, C. C., & van Heerikhuizen, H. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01115-1 · Cited by 165 · see citing works
Paré, D., Smith, Y., & Paré, J.-F. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00272-k · Cited by 164 · see citing works
Bussey, T. J., Everitt, B. J., & Robbins, T. W. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.5.908 · Cited by 163 · see citing works
Rodgers, R. J., Cole, J. C., Aboualfa, K., & Stephenson, L. H. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00190-8 · Cited by 157 · see citing works
Fogaça, M. V., Reis, F. M. C. V., Campos, A. C., & Guimarães, F. S. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.012 · Cited by 153 · see citing works
Guimarães, F. S., Carobrez, A. P., Aguiar, J. C. D., & Graeff, F. G. (1991) · Psychopharmacology · doi:10.1007/bf02244080 · Cited by 151 · see citing works
Lemos, J. I., Resstel, L. B., & Guimarães, F. S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.09.045 · Cited by 146 · see citing works
Restraint-induced hypoactivity in an elevated plus-maze
Padovan, C. M., & Guimarães, F. S. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000000100011 · Cited by 133 · see citing works
Cai, X., Gu, Z., Zhong, P., Ren, Y., & Yan, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203752200 · Cited by 130 · see citing works
Modulation of medial prefrontal cortical activity using in vivo recordings and optogenetics
Ji, G., & Neugebauer, V. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-36 · Cited by 130 · see citing works
A role for the prefrontal cortex in recall of recent and remote memories
Blum, S., Hebert, A. E., & Dash, P. (2006) · NeuroReport · doi:10.1097/01.wnr.0000201509.53750.bc · Cited by 127 · see citing works
Stressor Controllability, Anxiety, and Serotonin
Maier, S. F., & Watkins, L. R. (1998) · Cognitive Therapy and Research · doi:10.1023/a:1018794104325 · Cited by 123 · see citing works
Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat.
Krieger, J. E., & Graeff, F. G. (1985) · PubMed · Cited by 113 · see citing works
Cheng, L.-L., Wang, S., & Gean, P. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00229.x · Cited by 113 · see citing works
Enhanced excitability in the infralimbic cortex produces anxiety-like behaviors
Bi, L., Wang, J., Luo, Z.-Y., Chen, S., Geng, F., Chen, Y., Li, S.-J., Yuan, C., Lin, S., & Gao, T. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.048 · Cited by 108 · see citing works
Serotonergic activation reduces defensive freezing in the conditioned fear paradigm
Inoue, T. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02084-5 · Cited by 106 · see citing works
Tavares, R. F., Corrêa, F. M. D. A., & Resstel, L. B. M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22070 · Cited by 98 · see citing works
Gomes, F. V., Reis, D. G., Alves, F. H., Corrêa, F. M., Guimarães, F. S., & Resstel, L. B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881110389095 · Cited by 97 · see citing works
Angiotensin, LDL peroxidation and atherosclerosis
Keidar, S. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00014-9 · Cited by 93 · see citing works
Understanding the physiological roles of the neuronal calcium sensor proteins
Burgoyne, R. D., & Haynes, L. P. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-2 · Cited by 90 · see citing works
The neuroanatomical basis of anxiety
Pratt, J. A. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90014-q · Cited by 89 · see citing works
Groenink, L., Pattij, T., de Jongh, R., van der Gugten, J., Oosting, R. S., Dirks, A., & Olivier, B. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01281-0 · Cited by 89 · see citing works
Autonomic Changes Associated with Enhanced Anxiety in 5-HT1A Receptor Knockout Mice
Pattij, T. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00317-2 · Cited by 78 · see citing works
Campos, A. C., Ferreira, F. R., Guimarães, F. S., & Lemos, J. I. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.062 · Cited by 75 · see citing works
Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety
Russo, A., Guimarães, F. S., Aguiar, J. C. D., & Graeff, F. G. (1993) · Psychopharmacology · doi:10.1007/bf02246973 · Cited by 67 · see citing works
Resstel, L. B. M., de Souza, R. F., & Guimarães, F. S. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.08.009 · Cited by 64 · see citing works
Lisboa, S. F. D. S., Stecchini, M. F., Corrêa, F. M. D. A., Guimarães, F. S., & Resstel, L. B. M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.048 · Cited by 62 · see citing works
Ishida, Y., Hashiguchi, H., Takeda, R., Ishizuka, Y., Mitsuyama, Y., Kannan, H., Nishimori, T., & Nakahara, D. (2002) · Synapse · doi:10.1002/syn.10086 · Cited by 59 · see citing works
Behavioural responses to single and repeated restraint in male and female rats
Albonetti, M. E., & Farabollini, F. (1992) · Behavioural Processes · doi:10.1016/0376-6357(92)90052-f · Cited by 59 · see citing works
Matheus, M. G., & Guimarães, F. S. (1997) · Psychopharmacology · doi:10.1007/s002130050314 · Cited by 57 · see citing works
Reis, F. M., Albrechet‐Souza, L., Franci, C. R., & Brandão, M. L. (2011) · Stress · doi:10.3109/10253890.2011.623740 · Cited by 31 · see citing works
Wang, S., Coutinho, V., & Sihra, T. S. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705045 · Cited by 28 · see citing works
Serotonin 1A receptors in mood disorders: a combined genetic and genomic approach
Sibille, E. L., & Hen, R. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00003 · Cited by 24 · see citing works
Molchanov, M. L., & Guimarães, F. S. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999001200013 · Cited by 22 · see citing works
Distinct behavioral consequences of stress models of depression in the elevated T-maze
Soares-Rachetti, V. D. P., Vicente, M. A., Biojone, C., Zangrossi, H., Guimarães, F. S., & Joca, S. R. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.032 · Cited by 18 · see citing works
Lin, C., Huang, Y., Tsai, J., & Gean, P. (2001) · Synapse · doi:10.1002/syn.1092 · Cited by 16 · see citing works
Understanding mental disorders through Woody Allen's films
Cheniaux, E., & Landeira-Fernández, J. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462013000100021 · Cited by 11 · see citing works
Mendonça, F. H., Fh, F., Del-Bel, E. A., & Fs, G. (1996) · PubMed · Cited by 6 · see citing works
Anxiolytic effect of midazolam microinjected into the dorsal periaqueductal grey area of rats.
Russo, A., Guimarães, F. S., Aguiar, J. C. D., & Graeff, F. G. (1991) · PubMed · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cannabidiol: State of the art and new challenges for therapeutic applications
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M., Fiore, D., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.041 · Cited by 625 · see citing works
Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 482 · see citing works
Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age
Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308 · see citing works
García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020) · Biomolecules · doi:10.3390/biom10111575 · Cited by 306 · see citing works
Baron, E. P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 256 · see citing works
The endocannabinoid system as a target for novel anxiolytic drugs
Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233 · see citing works
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Bonaccorso, S., Ricciardi, A., Zangani, C., Chiappini, S., & Schifano, F. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.002 · Cited by 170 · see citing works
González‐Cuevas, G., Martin‐Fardon, R., Kerr, T. M., Stouffer, D. G., Parsons, L. H., Hammell, D. C., Banks, S. L., Stinchcomb, A. L., & Weiss, F. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0050-8 · Cited by 157 · see citing works
The Polypharmacological Effects of Cannabidiol
Castillo-Arellano, J. I., Canseco-Alba, A., Cutler, S. J., & León, F. (2023) · Molecules · doi:10.3390/molecules28073271 · Cited by 163 · see citing works
Lee, J. L. C., Bertoglio, L. J., Guimarães, F. S., & Stevenson, C. W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13724 · Cited by 140 · see citing works
Luján, M. Á., Castro‐Zavala, A., Alegre-Zurano, L., & Valverde, O. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.043 · Cited by 130 · see citing works
Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
Gonçalves, E. C. D., Baldasso, G. M., Bicca, M. A., Paes, R. S., Capasso, R., & Dutra, R. C. (2020) · Molecules · doi:10.3390/molecules25071567 · Cited by 111 · see citing works
Cannabinoid Regulation of Fear and Anxiety: an Update
Papagianni, E. P., & Stevenson, C. W. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1026-z · Cited by 100 · see citing works
Štark, T., Kučerová, J., Iannotti, F. A., D’Addario, C., Marco, R. D., Pekařík, V., Dražanová, E., Piscitelli, F., Bari, M., Babinská, Z., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.035 · Cited by 89 · see citing works
Kasten, C. R., Zhang, Y., & Boehm, S. L. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00032 · Cited by 86 · see citing works
Norris, C., Loureiro, M., Kramar, C. P., Zunder, J. S., Renard, J., Rushlow, W. J., & Laviolette, S. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.93 · Cited by 75 · see citing works
dos Santos, A. H., Lisboa, S. F. D. S., Sonego, A. B., Coutinho, D., Gomes, F. V., & Guimarães, F. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109637 · Cited by 67 · see citing works
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Naya, N. M., Kelly, J., Corna, G., Golino, M., Polizio, A. H., Abbate, A., Toldo, S. A., & Mezzaroma, E. (2024) · Molecules · doi:10.3390/molecules29020473 · Cited by 73 · see citing works
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
Jurkus, R., Day, H. L. L., Guimarães, F. S., Lee, J. L. C., Bertoglio, L. J., & Stevenson, C. W. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00454 · Cited by 58 · see citing works
Morris, E. M., Kitts-Morgan, S. E., Spangler, D. M., McLeod, K. R., Costa, J. H. C., & Harmon, D. L. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.569565 · Cited by 55 · see citing works
Luján, M. Á., Cantacorps, L., & Valverde, O. (2019) · Addiction Biology · doi:10.1111/adb.12778 · Cited by 54 · see citing works
Yao, Y., Ge, L., Yu, Q., Du, X., Zhang, X., Taylor‐Piliae, R. E., & Wei, G. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5549006 · Cited by 53 · see citing works
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Austrich-Olivares, A., García‐Gutiérrez, M. S., Illescas, L., Gasparyan, A., & Manzanares, J. (2022) · Pharmaceuticals · doi:10.3390/ph15040473 · Cited by 49 · see citing works
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction
Song, C., Stevenson, C. W., Guimarães, F. S., & Lee, J. L. C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00493 · Cited by 46 · see citing works
Viudez‐Martínez, A., García‐Gutiérrez, M. S., & Manzanares, J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118805495 · Cited by 43 · see citing works
Assareh, N., Gururajan, A., Zhou, C., Luo, J. L., Kevin, R. C., & Arnold, J. C. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000565 · Cited by 40 · see citing works
Salviato, B. Z., Raymundi, A. M., da Silva, T. R., Salemme, B. W., Sohn, J. M. B., de Araujo, F. S., Guimarães, F. S., Bertoglio, L. J., & Stern, C. A. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108684 · Cited by 35 · see citing works
Cannabinoids: Revealing their complexity and role in central networks of fear and anxiety
Murkar, A., Koninck, J. D., & Merali, Z. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.002 · Cited by 34 · see citing works
Support for Natural Small-Molecule Phenols as Anxiolytics
Wang, X., Chen, Y., Wang, Q., Sun, L. Z., Li, G., Zhang, C., Huang, J., Chen, L., & Zhai, H. (2017) · Molecules · doi:10.3390/molecules22122138 · Cited by 32 · see citing works
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Alexander, C., Jeon, J., Nickerson, K., Hassler, S. N., & Vasefi, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116742 · Cited by 28 · see citing works
Learning and memory is modulated by cannabidiol when administered during trace fear-conditioning
Uhernik, A. L., Montoya, Z. T., Balkissoon, C. D., & Smith, J. P. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.02.009 · Cited by 28 · see citing works
Mendiguren, A., Aostri, E., Rodilla, I., Pujana, I., Noskova, E., & Pineda, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1183019 · Cited by 27 · see citing works
Bayer, H., Stern, C. A. J., Troyner, F., Gazarini, L., Guimarães, F. S., & Bertoglio, L. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108913 · Cited by 27 · see citing works
Franzen, J. M., Werle, I., Vanz, F., de Oliveira, B. B., Nascimento, L. M. M., Guimarães, F. S., & Bertoglio, L. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109316 · Cited by 27 · see citing works
Werle, I., Nascimento, L. M. M., dos Santos, A. L. A., Soares, L. A., SANTOS, R. G. D., Hallak, J. E. C., & Bertoglio, L. J. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16315 · Cited by 28 · see citing works
The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol
dos Santos, A. H., Vila-Verde, C., Guimarães, F. S., Joca, S. R. L., & Lisboa, S. F. D. S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411101217 · Cited by 20 · see citing works
Anticonvulsant and Neuroprotective Effects of Cannabidiol During the Juvenile Period
Friedman, L. K., & Wongvravit, J. P. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly069 · Cited by 20 · see citing works
Considerations for Cannabinoids in Perioperative Care by Anesthesiologists
Laudański, K., & Wain, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030558 · Cited by 22 · see citing works
Stephens, E. K., Baker, A. L., & Gulledge, A. T. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00002 · Cited by 19 · see citing works
Khan, A. U., Falconi‐Sobrinho, L. L., dos Anjos‐Garcia, T., Sampaio, M. D. F. D. S., Crippa, J. A. S., Menescal-de-Oliveira, L., & Coimbra, N. C. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05435-5 · Cited by 18 · see citing works
Chu, J., Deyama, S., Li, X., Motono, M., Otoda, A., Saito, A., Esaki, H., Nishitani, N., & Kaneda, K. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135555 · Cited by 19 · see citing works
Franzen, J. M., Vanz, F., Werle, I., Guimarães, F. S., & Bertoglio, L. J. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.08.002 · Cited by 16 · see citing works
Mendiguren, A., Aostri, E., Alberdi, E. M., Pérez‐Samartín, A., & Pineda, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.956886 · Cited by 13 · see citing works
Hu, Z., Qin, Z., Xie, J., Qu, Y., & Yin, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116271 · Cited by 15 · see citing works
Ghovanloo, M., Dib‐Hajj, S. D., Goodchild, S. J., Ruben, P. C., & Waxman, S. G. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1066455 · Cited by 14 · see citing works
Cannabidiol effects on prepulse inhibition in nonhuman primates
Saletti, P. G., & Tomaz, C. A. B. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0101 · Cited by 13 · see citing works
García‐Gutiérrez, M. S., Navarro, D., Austrich-Olivares, A., & Manzanares, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1171646 · Cited by 12 · see citing works
Lisboa, S. F. D. S., Stern, C. A. J., Gazarini, L., & Bertoglio, L. J. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.03.007 · Cited by 12 · see citing works
Hernandes, P. M., Batistela, M. F., Nascimento‐Silva, J. M., Frias, A. T., Matthiesen, M., Campos, A. C., Lovick, T. A., & Zangrossi, H. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114663 · Cited by 12 · see citing works
Borges‐Assis, A. B., Uliana, D. L., Hott, S. C., Guimarães, F. S., Lisboa, S. F. D. S., & Resstel, L. B. M. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110739 · Cited by 11 · see citing works
Almeida‐Santos, A. F., Moreira, F. A., Guimarães, F. S., & de Aguiar, D. C. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117704986 · Cited by 11 · see citing works
Is cannabidiol (CBD) effective to ease separation anxiety?
Masataka, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25851 · Cited by 10 · see citing works
Fragile X Syndrome and Targeted Treatments
Tassanakijpanich, N., Cabal-Herrera, A. M., Salcedo‐Arellano, M. J., & Hagerman, R. J. (2020) · Journal of Biomedicine and Translational Research · doi:10.14710/jbtr.v6i1.7321 · Cited by 10 · see citing works
Nicotine and fluoxetine alter adolescent dopamine-mediated behaviors via 5-HT1A receptor activation
Yuan, M., & Leslie, F. M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1380123 · Cited by 6 · see citing works
Cannabidiol in anxiety disorders: Current and future perspectives
Simei, J. L. Q., Souza, J. D. R., Lisboa, J. R., Guimarães, F. S., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.003 · Cited by 7 · see citing works
Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats
Gom, R. C., Wickramarachchi, P., George, A. G., Lightfoot, S. H. M., Newton-Gunderson, D., Hill, M. N., Teskey, G. C., & Colangeli, R. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02005-y · Cited by 4 · see citing works
A Review of Recent Advances in the Therapeutic Uses of Secondary Cannabinoids
Morabito, D. M., Soyster, P. D., Ramey-Wright, S., Belendiuk, K. A., & Bonn‐Miller, M. O. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0096-9 · Cited by 4 · see citing works
Silva, M. H. (2023) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2023.00017 · Cited by 2 · see citing works
O uso de canabinoides no tratamento da ansiedade
Zanellati, D., & Rodríguez, V. (2021) · Revista Brasileira Militar de Ciências · doi:10.36414/rbmc.v7i18.97 · Cited by 2 · see citing works
Neurotoxicity and neuroprotection induced by plant-derived cannabinoids
Silva, M. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00071-3 · Cited by 1 · see citing works
Kasten, C. R. (2017) · Purdue University Indianapolis (Indiana University) · doi:10.7912/c2/1111
Rao, P., & Morandini, H. A. E. (2023) · Journal of Indian Association for Child and Adolescent Mental Health · doi:10.1177/09731342231179036
da Cruz, L. D. M. A., dos Santos, J. R. B., & Matheus, M. E. (2023) · Amplla Editora eBooks · doi:10.51859/amplla.ame553.1123-0
Cannabinoids: Adaptogens or Not?
Karp, F., & León, I. E. (2025) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0108
Canabidiol, ansiedade e memórias aversivas: uma revisão das evidências pré-clínicas
Portes, M. A. M., Werle, I., Soares, L. A., Guterres, F. D. S., & Bertoglio, L. J. (2025) · Revista Fitos · doi:10.32712/2446-4775.2025.1817
Boury‐Esnault, N., Marschal, C., Probst, J.-M. K., & Barnathan, G. (2002) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.155630
- Authors
- Marinho, A. L. Z., Vila-Verde, C., Fogaça, M. V., & Guimarães, F. S.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Marinho, A.L.Z.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 286
- Pages
- 49-56
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W2005001650
- Cited by
- 68
- References
- 95
- Citations by year
- 2025: 3 · 2024: 9 · 2023: 8 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 10 · 2017: 6 · 2016: 5
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
- Keywords
- cannabidiol, infralimbic cortex, 5-HT1A receptor, serotonin, anxiety, contextual fear conditioning, elevated plus maze, restraint stress, WAY-100635, microinjection, defensive behavior, emotional behavior
- MeSH terms
- Animals, Anxiety, Cannabidiol, Conditioning, Psychological, Dose-Response Relationship, Drug, Electroshock, Exploratory Behavior, Fear, Foot, Male, Microinjections, Piperazines, Psychotropic Drugs, Pyridines, Restraint, Physical, Stress, Psychological, Rats, Wistar, Prefrontal Cortex, Receptor, Serotonin, 5-HT1A, Serotonin 5-HT1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
